Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1724-6059
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project ; day:2 ; month:12 ; year:2022 ; pages:1-7
Journal of nephrology ; (2.12.2022), 1-7
- Creator
-
Alkas, Jim
Bosi, Alessandro
Sjölander, Arvid
Barany, Peter
Elinder, Carl-Gustaf
Fu, Edouard L.
Carrero, Juan Jesus
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40620-022-01505-8
- URN
-
urn:nbn:de:101:1-2023021321005732444112
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alkas, Jim
- Bosi, Alessandro
- Sjölander, Arvid
- Barany, Peter
- Elinder, Carl-Gustaf
- Fu, Edouard L.
- Carrero, Juan Jesus
- SpringerLink (Online service)
Other Objects (12)
SGLT2i: beyond the glucose-lowering effect
Pharmacogenetics of novel glucose-lowering drugs
The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
Routine serum creatinine measurements: how well do we perform?
Diabetes, bone and glucose-lowering agents: basic biology
Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project
Cardiovascular outcome trials of glucose-lowering medications: an update
The effects of yam gruel on lowering fasted blood glucose in T2DM rats
Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect
Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis
Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations
Between women : lowering the barriers
SGLT2i: beyond the glucose-lowering effect
Pharmacogenetics of novel glucose-lowering drugs
The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
Routine serum creatinine measurements: how well do we perform?
Diabetes, bone and glucose-lowering agents: basic biology
Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project
Cardiovascular outcome trials of glucose-lowering medications: an update
The effects of yam gruel on lowering fasted blood glucose in T2DM rats
Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect
Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis
Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations
Between women : lowering the barriers
SGLT2i: beyond the glucose-lowering effect
Pharmacogenetics of novel glucose-lowering drugs
The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
Routine serum creatinine measurements: how well do we perform?
Diabetes, bone and glucose-lowering agents: basic biology
Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project
Cardiovascular outcome trials of glucose-lowering medications: an update
The effects of yam gruel on lowering fasted blood glucose in T2DM rats
Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect
Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis
Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations